CN113519687B - Infant milk protein partial hydrolysis formula food for special medical use - Google Patents
Infant milk protein partial hydrolysis formula food for special medical use Download PDFInfo
- Publication number
- CN113519687B CN113519687B CN202110831539.1A CN202110831539A CN113519687B CN 113519687 B CN113519687 B CN 113519687B CN 202110831539 A CN202110831539 A CN 202110831539A CN 113519687 B CN113519687 B CN 113519687B
- Authority
- CN
- China
- Prior art keywords
- percent
- whey protein
- hydrolyzed
- hydrolyzed whey
- alkaline protease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 235000013350 formula milk Nutrition 0.000 title claims abstract description 29
- 230000007062 hydrolysis Effects 0.000 title claims abstract description 22
- 238000006460 hydrolysis reaction Methods 0.000 title claims abstract description 22
- 235000013305 food Nutrition 0.000 title claims abstract description 16
- 102000014171 Milk Proteins Human genes 0.000 title claims abstract description 7
- 108010011756 Milk Proteins Proteins 0.000 title claims abstract description 7
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 78
- 235000021119 whey protein Nutrition 0.000 claims abstract description 78
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 73
- 108091005658 Basic proteases Proteins 0.000 claims abstract description 19
- 230000003301 hydrolyzing effect Effects 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 claims description 22
- 238000000034 method Methods 0.000 claims description 15
- 229940048086 sodium pyrophosphate Drugs 0.000 claims description 14
- 235000019818 tetrasodium diphosphate Nutrition 0.000 claims description 14
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 claims description 14
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 12
- 102000004190 Enzymes Human genes 0.000 claims description 11
- 108090000790 Enzymes Proteins 0.000 claims description 11
- 235000019871 vegetable fat Nutrition 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 9
- 239000000758 substrate Substances 0.000 claims description 7
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 7
- 239000008158 vegetable oil Substances 0.000 claims description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 6
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 6
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims description 6
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims description 6
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims description 6
- 239000011575 calcium Substances 0.000 claims description 6
- 229910052791 calcium Inorganic materials 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 6
- 229930195729 fatty acid Natural products 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- 150000003904 phospholipids Chemical class 0.000 claims description 6
- 229960001295 tocopherol Drugs 0.000 claims description 6
- 235000010384 tocopherol Nutrition 0.000 claims description 6
- 239000011732 tocopherol Substances 0.000 claims description 6
- 229930003799 tocopherol Natural products 0.000 claims description 6
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 6
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 5
- 229960005055 sodium ascorbate Drugs 0.000 claims description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 4
- 239000011707 mineral Substances 0.000 claims description 4
- 235000010755 mineral Nutrition 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims description 3
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 3
- 229920002774 Maltodextrin Polymers 0.000 claims description 3
- 239000005913 Maltodextrin Substances 0.000 claims description 3
- 229920002472 Starch Polymers 0.000 claims description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- 239000001506 calcium phosphate Substances 0.000 claims description 3
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 claims description 3
- 229960001231 choline Drugs 0.000 claims description 3
- 239000006071 cream Substances 0.000 claims description 3
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 3
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 3
- 229960000367 inositol Drugs 0.000 claims description 3
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 3
- 239000008101 lactose Substances 0.000 claims description 3
- 229940035034 maltodextrin Drugs 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims description 3
- 125000003729 nucleotide group Chemical group 0.000 claims description 3
- 239000001103 potassium chloride Substances 0.000 claims description 3
- 235000011164 potassium chloride Nutrition 0.000 claims description 3
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- 239000007787 solid Substances 0.000 claims description 3
- 239000008107 starch Substances 0.000 claims description 3
- 235000019698 starch Nutrition 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 3
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 3
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 3
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 3
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 3
- 235000019197 fats Nutrition 0.000 claims description 2
- 230000002255 enzymatic effect Effects 0.000 claims 2
- 239000000796 flavoring agent Substances 0.000 abstract description 11
- 235000019634 flavors Nutrition 0.000 abstract description 11
- 102000008192 Lactoglobulins Human genes 0.000 abstract description 10
- 108010060630 Lactoglobulins Proteins 0.000 abstract description 10
- 206010070834 Sensitisation Diseases 0.000 abstract description 4
- 230000008313 sensitization Effects 0.000 abstract description 4
- 102000004142 Trypsin Human genes 0.000 abstract description 2
- 108090000631 Trypsin Proteins 0.000 abstract description 2
- 239000012588 trypsin Substances 0.000 abstract description 2
- 239000004365 Protease Substances 0.000 description 13
- 235000013336 milk Nutrition 0.000 description 12
- 239000008267 milk Substances 0.000 description 12
- 210000004080 milk Anatomy 0.000 description 12
- 229940088598 enzyme Drugs 0.000 description 10
- 108091005804 Peptidases Proteins 0.000 description 7
- 108090000526 Papain Proteins 0.000 description 6
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 6
- 229940055729 papain Drugs 0.000 description 6
- 235000019834 papain Nutrition 0.000 description 6
- 235000019419 proteases Nutrition 0.000 description 6
- 206010020751 Hypersensitivity Diseases 0.000 description 5
- 208000009793 Milk Hypersensitivity Diseases 0.000 description 5
- 201000010859 Milk allergy Diseases 0.000 description 5
- 208000026935 allergic disease Diseases 0.000 description 5
- 230000007815 allergy Effects 0.000 description 5
- 108090000765 processed proteins & peptides Proteins 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 108010007119 flavourzyme Proteins 0.000 description 4
- 238000003556 assay Methods 0.000 description 3
- 235000020247 cow milk Nutrition 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 230000000774 hypoallergenic effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical compound O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- MJVAVZPDRWSRRC-UHFFFAOYSA-N Menadione Chemical compound C1=CC=C2C(=O)C(C)=CC(=O)C2=C1 MJVAVZPDRWSRRC-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 239000013566 allergen Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 201000005356 cow milk allergy Diseases 0.000 description 2
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 2
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical compound [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 2
- 239000011755 sodium-L-ascorbate Substances 0.000 description 2
- 235000019187 sodium-L-ascorbate Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 208000016557 Acute basophilic leukemia Diseases 0.000 description 1
- GUBGYTABKSRVRQ-DCSYEGIMSA-N Beta-Lactose Chemical compound OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-DCSYEGIMSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 239000011665 D-biotin Substances 0.000 description 1
- 235000000638 D-biotin Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- POLBLONFVZXVPI-UHFFFAOYSA-N N-methyl-sec-pseudobrucine Natural products O=C1CC2C3C(CC4=O)OCC=C2CN(C)CCC11C3N4C2=C1C=C(OC)C(OC)=C2 POLBLONFVZXVPI-UHFFFAOYSA-N 0.000 description 1
- FLBVMURVUYAZMG-UHFFFAOYSA-N Novacin Natural products CN1CCC23C4C5C(CC(=O)N4c6cc(C)c(C)cc26)OCC=C(C1)C5CC3=O FLBVMURVUYAZMG-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 102000007079 Peptide Fragments Human genes 0.000 description 1
- 108010033276 Peptide Fragments Proteins 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- XBJFCYDKBDVADW-UHFFFAOYSA-N acetonitrile;formic acid Chemical compound CC#N.OC=O XBJFCYDKBDVADW-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- 229960000355 copper sulfate Drugs 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 229960002104 cyanocobalamin Drugs 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 235000021245 dietary protein Nutrition 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 229960001781 ferrous sulfate Drugs 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000013568 food allergen Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 229960003390 magnesium sulfate Drugs 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000020615 partially hydrolysed formula Nutrition 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical compound [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 description 1
- 239000001230 potassium iodate Substances 0.000 description 1
- 235000006666 potassium iodate Nutrition 0.000 description 1
- 229940093930 potassium iodate Drugs 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000003257 protein preparation method Methods 0.000 description 1
- 239000012460 protein solution Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- -1 sodium pyrophosphate compound Chemical class 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 1
- 235000005282 vitamin D3 Nutrition 0.000 description 1
- 239000011647 vitamin D3 Substances 0.000 description 1
- 235000012711 vitamin K3 Nutrition 0.000 description 1
- 239000011652 vitamin K3 Substances 0.000 description 1
- 229940021056 vitamin d3 Drugs 0.000 description 1
- 229940041603 vitamin k 3 Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229930195724 β-lactose Natural products 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
- A23J3/08—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1522—Inorganic additives, e.g. minerals, trace elements; Chlorination or fluoridation of milk; Organic salts or complexes of metals other than natrium or kalium; Calcium enrichment of milk
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1526—Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/1528—Fatty acids; Mono- or diglycerides; Petroleum jelly; Paraffine; Phospholipids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/156—Flavoured milk preparations ; Addition of fruits, vegetables, sugars, sugar alcohols or sweeteners
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/152—Milk preparations; Milk powder or milk powder preparations containing additives
- A23C9/158—Milk preparations; Milk powder or milk powder preparations containing additives containing vitamins or antibiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/16—Agglomerating or granulating milk powder; Making instant milk powder; Products obtained thereby
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/30—Working-up of proteins for foodstuffs by hydrolysis
- A23J3/32—Working-up of proteins for foodstuffs by hydrolysis using chemical agents
- A23J3/34—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes
- A23J3/341—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins
- A23J3/343—Working-up of proteins for foodstuffs by hydrolysis using chemical agents using enzymes of animal proteins of dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Pediatric Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present application provides a partially hydrolysed infant milk protein formula for particular medical use comprising hydrolysed whey protein prepared by hydrolysing whey protein with an alkaline protease or trypsin. The formula food of the application can effectively reduce the beta-lactoglobulin sensitization of the formula food while maintaining good flavor through moderate hydrolysis.
Description
Technical Field
The present application belongs to the field of food products, in particular infant formula, and specifically provides an infant milk protein partial hydrolysis formula for special medical use, which comprises hydrolyzed whey protein prepared by hydrolyzing whey protein with alkaline protease or trypsin.
Background
Cow's milk is the main food protein source for infant to replace breast milk, but it is one of the most common food allergens (cow's milk allergy rate of preschool children can reach about 10%, and it still has about 3% in adult stage), and the preparation of cow's milk products or substitute formula foods for preventing allergy is very significant for cow's milk allergy people, especially for the health of infant cow's milk allergy people. Beta-lactoglobulin accounts for about 50% of the total amount of whey protein and is the main functional active component of whey protein. More than 80% of people with cow milk allergy belong to allergy to beta-lactoglobulin, and the probability of cow milk allergy occurrence can be effectively reduced by eliminating beta-lactoglobulin or allergen epitopes thereof.
The existing method for eliminating beta-lactoglobulin or allergen epitope thereof mainly comprises heat processing, high-pressure treatment, fermentation, radiation treatment, enzymolysis treatment and the like. Because the problems of difficult overcoming of the actual effect and safety of the thermal processing, the high-pressure treatment, the fermentation and the radiation treatment exist, the enzymolysis treatment is still the mainstream method for producing the hypoallergenic dairy products/substitute formula foods.
On one hand, the beta-lactoglobulin has the characteristic of resisting protease hydrolysis due to the compact space folding structure of the beta-lactoglobulin; on the other hand, increasing the degree of hydrolysis (e.g. extensively hydrolyzed milk powder/whey protein or casein) can reduce allergenicity, but is generally accompanied by an increase in cost and a decrease in flavor; thus, controlling the hydrolysis process/degree is a key step in the preparation of hypoallergenic dairy/alternative formulas, and it is necessary to investigate hydrolysis patterns that further reduce allergenicity at lower hydrolysis levels (meaning better mouthfeel and lower cost).
Disclosure of Invention
The applicant researches the types of enzymes used for hydrolysis, the enzymolysis conditions and the additives added in the enzymolysis, and finds that the alkaline protease added with a proper amount of sodium pyrophosphate can effectively reduce the allergenicity under a proper hydrolysis degree and flavor by enzymolysis of the whey protein, so that the flavor and the low allergenicity are well balanced, and a good raw material is provided for formula food or milk powder.
Infant milk protein partially hydrolysed formula for special medical use, characterised in that it comprises hydrolysed whey protein; the hydrolyzed whey protein is prepared by hydrolyzing whey protein by alkaline protease or compound flavor protease.
Further, the ingredients in the formula food are as follows: 69.9 percent of vegetable fat powder C, 24 percent of vegetable fat powder E, 2 percent of fructo-oligosaccharide, 1.1 percent of choline, 0.7 percent of potassium chloride, 0.5 percent of calcium hydrophosphate, 0.5 percent of mineral substance, 0.3 percent of inositol, 0.3 percent of tricalcium phosphate, 0.3 percent of vitamin, 0.2 percent of sodium chloride, 0.1 percent of calcium carbonate, 0.05 percent of L-carnitine and 0.05 percent of nucleotide;
wherein the vegetable fat powder C is: 45% of lactose, 26% of hydrolyzed whey protein, 26.6% of compound vegetable oil, 1.4% of calcium hydrophosphate, 0.7% of mono-diglycerol fatty acid ester, 0.2% of L-sodium ascorbate, 0.033% of ascorbyl palmitate, 0.033% of phospholipid and 0.034% of mixed tocopherol concentrate;
the plant fat powder E is: 26.8% of solid starch sugar, 25% of anhydrous cream, 23% of hydrolyzed whey protein, 19.2% of maltodextrin, 5% of compound vegetable oil, 0.71% of mono-diglycerol fatty acid ester, 0.21% of L-sodium ascorbate, 0.03% of ascorbyl palmitate, 0.03% of phospholipid and 0.02% of mixed tocopherol concentrate;
further, the hydrolyzed whey protein preparation method comprises enzymolysis of whey protein with alkaline protease at an enzyme/substrate mass ratio of 7%
Further, sodium pyrophosphate with the mass of 0.1% of whey protein is added in the whey protein enzymolysis process.
Further, the enzymolysis conditions are as follows: pH 8.5, temperature 50 ℃, time 4 hours:
in another aspect, the present application provides a method for producing hydrolyzed whey protein, characterized in that the whey protein is enzymatically hydrolyzed with an alkaline protease at an enzyme/substrate mass ratio of 7%.
Further, sodium pyrophosphate with the mass of 0.1% of whey protein is added in the process of carrying out enzymolysis on the whey protein.
Further, the enzymolysis conditions are as follows: pH 8.5, temperature 50 ℃, time 4 hours;
in another aspect, the present application provides the use of the above hydrolyzed whey protein in the preparation of hypoallergenic food products.
Further, the food is infant milk powder or formula food.
Detailed Description
Primary reagents, instruments and methods
The whey protein is self-made by the applicant from an own milk source, and the same batch of products are used in the experimental process;
alkaline protease, complex flavourzyme: novacin;
papain: dong Heng Hua dao;
sodium pyrophosphate: sincere biotechnology limited;
KU812 (human peripheral blood basophilic leukemia cells): purchased from EK-bioscience;
beta-HEX ELISA detection kit: rui Xin biology;
liquid mass spectrometer: shimadzu LCMS-2020;
other reagents and ingredients are conventional domestic or imported varieties which meet the relevant regulations.
The enzymolysis method comprises the following steps:
preparing 10g/L whey protein solution with 5mM required PBS, adding required enzyme and sodium pyrophosphate, performing enzymolysis in a constant temperature water bath for a preset time (stirring at low speed), inactivating enzyme at 100 ℃ for 10 minutes, and then measuring or storing in a refrigerator freezing chamber for later use.
And (3) determining the degree of hydrolysis:
OPA (ortho-phthalaldehyde) method, in which 400. Mu.l of a sample or a serine control solution (0.1 g/L) was added to 3mLOPA reagent, reacted for 2 minutes, and then measured for absorbance at 340nm and calculated (detailed reagents and procedures refer to CHURCH F C et al, spectrophotometric assay Using o-chromatographic for Determination of protein in Milk and Isolated Milk Proteins, journal of Dairy Science,1983, vol.66, stage 6);
in addition, the molecular weight distribution of the hydrolyzed whey protein fragments was determined by SDS-PAGE electrophoresis.
Determination of level of sensitized cells:
serum from patients diagnosed with allergy to bovine milk beta-lactoglobulin (specific IgE >0.8 KUA/L) was obtained by a cooperative medical facility and the serum pool used for the test was a mixture of the sera from 25 patients.
Recovering and passaging the purchased cryopreserved KU812 cells; adding 2% cow milk beta-lactoglobulin serum (blank group is sterile buffer solution) into the culture medium, and incubating for 12 hours to enable the cells to be in a sensitized state; adding a sample with the protein concentration of 10mg/mL (a negative control group is sterile buffer solution) with the volume of 1% of the culture medium, and incubating for 6 hours; after Triton X-100 lysis, beta-HEX was detected using the above kit and the beta-HEX release rate was calculated: β -HEX release rate (100%) = (sample group OD value-negative group OD value)/(positive group OD value-negative group OD value) × 100%.
HPLC-MS detection
Taking hydrolyzed whey protein, diluting properly and then injecting a sample; mobile phase 1:0.1% aqueous formic acid, mobile phase 2:0.1% formic acid acetonitrile solution, and the mobile phase 2 is 0-100% in 0-60 minutes; electrospray positive ion mode, collision voltage 28ev; the PEAKS software analyzes the Swiss-Prot database.
Example 1 preparation of hydrolysed whey protein
Based on previous research experience and data of hydrolysis degree, time, bitterness value, flavor evaluation and the like in practical hydrolysis experiments (which are not shown here for reasons of space), three single-enzyme enzymolysis methods of alkaline protease, compound flavor protease and papain are selected from various available proteases and combinations thereof, and suitable enzymolysis conditions are further determined:
alkaline protease: 7% enzyme/substrate mass ratio, pH 8.5, temperature 50 ℃, time 4 hours;
compound flavor protease: 9% enzyme/substrate mass ratio, pH 7, temperature 50 ℃ for 4 hours;
papain: 6% enzyme/substrate mass ratio, pH 7, temperature 55 ℃ for 4 hours.
The following samples were prepared using the method described above:
unhydrolyzed whey protein: whey protein sample without any hydrolysis, heat treatment, pressure treatment, irradiation treatment;
hydrolyzed whey protein 1: carrying out enzymolysis by alkaline protease under the conditions;
hydrolyzed whey protein 2: carrying out enzymolysis on the compound flavourzyme under the conditions;
hydrolyzed whey protein 3: carrying out enzymolysis on the papain under the conditions;
hydrolyzed whey protein 4: adding sodium pyrophosphate alkaline protease accounting for 0.1 percent of the weight of the whey protein under the above conditions for enzymolysis;
hydrolyzed whey protein 5: adding sodium pyrophosphate compound flavourzyme with the mass of 0.1 percent of whey protein under the above conditions for enzymolysis;
hydrolyzed whey protein 6: adding 0.1% of sodium pyrophosphate papain in the mass of whey protein under the conditions for enzymolysis;
hydrolyzed whey protein 7: adding sodium pyrophosphate alkaline protease accounting for 0.05 percent of the weight of the whey protein under the above conditions for enzymolysis;
hydrolyzed whey protein 8: adding 0.5% of sodium pyrophosphate alkaline protease in the amount of whey protein under the above conditions for enzymolysis;
example 2 basic Properties of hydrolysed whey proteins
Determination of the degree of hydrolysis:
the hydrolysis of the hydrolyzed whey proteins 1 to 8, as measured by the OPA method and observed by SDS electrophoresis, is shown in the following table:
table 1 hydrolysis of various hydrolyzed whey proteins:
the result shows that the enzymolysis effect of the alkaline protease and the compound flavor protease is better than that of the papain, and the size of the hydrolyzed fragment is obviously different from that of deep hydrolysis (generally, the 3kDa fragment is more than 90%). The taste and flavor of the formula (specific formula is shown in the following examples) prepared by the hydrolyzed whey protein 4 are higher than those of the deeply hydrolyzed formula (multiple protease complex enzymes are hydrolyzed for a long time) prepared by the applicant and certain brand of deeply hydrolyzed milk powder sold in the market (specific scheme and data are not shown for reasons of space) according to the evaluation of scores, and the general understanding of the difference between the partially hydrolyzed milk powder and the deeply hydrolyzed milk powder is also met.
Example 3 sensitization assay and residual peptide short assay
The method is used for detecting the release rate of the beta-HEX of the unhydrolyzed whey protein, the hydrolyzed whey protein 1-8 and the commercially available deeply hydrolyzed milk powder, and the results are as follows:
TABLE 2 beta-HEX Release rates for various hydrolyzed whey proteins
Sample(s) | beta-HEX Release Rate (%) |
Unhydrolyzed whey protein | 44.51 |
Hydrolysed whey protein 1 | 29.22 |
Hydrolyzed whey protein 2 | 28.75 |
Hydrolyzed whey protein 3 | 37.41 |
Hydrolyzed whey protein 4 | 20.34 |
Hydrolysed whey protein 5 | 27.69 |
Hydrolyzed whey protein 6 | 36.71 |
Hydrolyzed whey protein 7 | 22.45 |
Hydrolyzed whey protein 8 | 23.96 |
Commercially available milk powder with certain degree of deep hydrolysis | 19.85 |
In combination with the results of example 2, it can be seen that the addition of a suitable amount of sodium pyrophosphate to complex the metal components in whey protein or to effect emulsification can change the protein conformation (presumably to be verified) so that certain sensitization key sites are exposed and then hydrolyzed by alkaline protease, probably because of the exposed sites, the combination of compound flavourzyme and sodium pyrophosphate cannot achieve the effect similar to that of alkaline protease. The release rate of the beta-HEX of the hydrolyzed whey protein 4 is close to the level of certain deeply hydrolyzed milk powder sold in the market (after the milk powder is prepared according to experience, the sensitization is slightly increased by 2-3 percent, but the amplitude is not too large), but the hydrolyzed whey protein 4 is obviously superior to deeply hydrolyzed products in flavor and manufacturing cost.
Further detecting residual peptide segments in the hydrolyzed whey proteins 1 and 4 by the HPLC-MS method, and finding residual peptide segments of 1-9, 34-40, 42-60, 73-82, 93-101, 87-94 and 140-149 of the beta-lactoglobulin in the hydrolyzed whey protein 1, wherein the residual peptide segments respectively have corresponding allergic epitopes; whereas no 34-40 peptide fragment was detected in hydrolysed whey protein 4 (corresponding to IgE epitopes 21-40, fritsche R. Et al, igE-mediated rat map cell triggering with typing and synthetic peptides of bone beta-lactose, int Arch Allergy Immunol,2005, vol. 138, no. 4).
Example 4 preparation of actual products of formula food
The hydrolyzed whey protein 4 is actually prepared into formula food, and the specific formula is as follows:
69.9 percent of vegetable fat powder C, 24 percent of vegetable fat powder E, 2 percent of fructo-oligosaccharide, 1.1 percent of choline, 0.7 percent of potassium chloride, 0.5 percent of calcium hydrophosphate, 0.5 percent of mineral substance, 0.3 percent of inositol, 0.3 percent of tricalcium phosphate, 0.3 percent of vitamin, 0.2 percent of sodium chloride, 0.1 percent of calcium carbonate, 0.05 percent of L-carnitine and 0.05 percent of nucleotide;
wherein the vegetable fat powder C is: 45% of lactose, 26% of hydrolyzed whey protein, 26.6% of compound vegetable oil, 1.4% of calcium hydrophosphate, 0.7% of mono-diglycerol fatty acid ester, 0.2% of L-sodium ascorbate, 0.033% of ascorbyl palmitate, 0.033% of phospholipid and 0.034% of mixed tocopherol concentrate;
the vegetable fat powder E is: 26.8% of solid starch sugar, 25% of anhydrous cream, 23% of hydrolyzed whey protein, 19.2% of maltodextrin, 5% of compound vegetable oil, 0.71% of mono-diglycerol fatty acid ester, 0.21% of sodium L-ascorbate, 0.03% of ascorbyl palmitate, 0.03% of phospholipid and 0.02% of mixed tocopherol concentrate
The minerals comprise copper sulfate, magnesium sulfate, ferrous sulfate, zinc sulfate, manganese sulfate, potassium iodate, and sodium selenite;
vitamins include retinyl acetate, cholecalciferol, dl-alpha-tocopherol acetate, menadione, thiamine hydrochloride, riboflavin, pyridoxine hydrochloride, cyanocobalamin, nicotinamide, folic acid, D-calcium pantothenate, sodium L-ascorbate, and D-biotin;
the composite vegetable oil comprises sunflower seed oil, soybean oil, low erucic acid rapeseed oil, coconut oil and corn oil.
Through evaluation and trial, the formula food has good taste, effectively avoids the allergy of infants, and is superior to the existing partial hydrolysis products.
Claims (4)
1. Infant milk protein partial hydrolysis formula for special medical use, characterized in that the formula comprises the following components: 69.9 percent of vegetable fat powder C, 24 percent of vegetable fat powder E, 2 percent of fructo-oligosaccharide, 1.1 percent of choline, 0.7 percent of potassium chloride, 0.5 percent of calcium hydrophosphate, 0.5 percent of mineral substance, 0.3 percent of inositol, 0.3 percent of tricalcium phosphate, 0.3 percent of vitamin, 0.2 percent of sodium chloride, 0.1 percent of calcium carbonate, 0.05 percent of L-carnitine and 0.05 percent of nucleotide; wherein the vegetable fat powder C comprises the following components: 45% of lactose, 26% of hydrolyzed whey protein, 26.6% of compound vegetable oil, 1.4% of calcium hydrophosphate, 0.7% of mono-diglycerol fatty acid ester, 0.2% of L-sodium ascorbate, 0.033% of ascorbyl palmitate, 0.033% of phospholipid and 0.034% of mixed tocopherol concentrate; wherein the plant fat powder E comprises the following components: 26.8% of solid starch sugar, 25% of anhydrous cream, 23% of hydrolyzed whey protein, 19.2% of maltodextrin, 5% of compound vegetable oil, 0.71% of mono-diglycerol fatty acid ester, 0.21% of L-sodium ascorbate, 0.03% of ascorbyl palmitate, 0.03% of phospholipid and 0.02% of mixed tocopherol concentrate;
the hydrolyzed whey protein is prepared by hydrolyzing whey protein with alkaline protease, and the preparation method of the hydrolyzed whey protein comprises adding alkaline protease with an enzyme/substrate mass ratio of 7% and sodium pyrophosphate with a whey protein mass ratio of 0.1% to carry out enzymolysis on the whey protein.
2. The food product of claim 1, wherein the enzymatic conditions during the preparation of the hydrolyzed whey protein are: pH 8.5, temperature 50 ℃ for 4 hours.
3. A preparation method of hydrolyzed whey protein is characterized in that alkaline protease with an enzyme/substrate mass ratio of 7% and sodium pyrophosphate with a whey protein mass ratio of 0.1% are added in the preparation method to carry out enzymolysis on the whey protein.
4. The method of claim 3, wherein the enzymatic conditions are: pH 8.5, temperature 50 ℃ for 4 hours.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110831539.1A CN113519687B (en) | 2021-07-22 | 2021-07-22 | Infant milk protein partial hydrolysis formula food for special medical use |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110831539.1A CN113519687B (en) | 2021-07-22 | 2021-07-22 | Infant milk protein partial hydrolysis formula food for special medical use |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113519687A CN113519687A (en) | 2021-10-22 |
CN113519687B true CN113519687B (en) | 2022-10-04 |
Family
ID=78088647
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110831539.1A Active CN113519687B (en) | 2021-07-22 | 2021-07-22 | Infant milk protein partial hydrolysis formula food for special medical use |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113519687B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114158736B (en) * | 2021-12-10 | 2022-10-04 | 青岛圣桐营养食品有限公司 | Compound vitamin suitable for full-nutrition formula food with special medical application |
CN114176219B (en) * | 2021-12-20 | 2022-10-04 | 青岛圣桐营养食品有限公司 | Hypoallergenic milk protein partial hydrolysis formula food and preparation method thereof |
CN116369535A (en) * | 2022-12-28 | 2023-07-04 | 海南健泰生物科技有限公司 | Quinoa weight-losing food and preparation method thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101297674B (en) * | 2008-04-03 | 2010-08-25 | 中国农业大学 | Subsensitive lactalbumin hydrolysate and preparation method thereof |
CN102940126B (en) * | 2012-11-16 | 2014-08-06 | 浙江贝因美科工贸股份有限公司 | Method for decreasing beta-lactoglobulin in concentrated whey albumen powder through biotic compound protein enzymolysis |
CN103621685B (en) * | 2013-12-05 | 2015-02-04 | 刘保惠 | Special medical infant formula milk powder with yak milk and preparation method thereof |
CN108294112B (en) * | 2018-01-12 | 2021-08-06 | 雅士利国际婴幼儿营养品有限公司 | Infant formula with optimized protein and amino acid patterns and preparation method thereof |
CN110387396A (en) * | 2019-08-28 | 2019-10-29 | 苏州恒瑞健康科技有限公司 | A kind of method for hydrolysis and PURE WHEY of lactoalbumin soln |
CN111972496A (en) * | 2020-08-25 | 2020-11-24 | 广州市美素力营养品有限公司 | Milk powder suitable for milk protein allergic high-risk infants |
-
2021
- 2021-07-22 CN CN202110831539.1A patent/CN113519687B/en active Active
Also Published As
Publication number | Publication date |
---|---|
CN113519687A (en) | 2021-10-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113519687B (en) | Infant milk protein partial hydrolysis formula food for special medical use | |
CN113519686B (en) | Infant milk protein partial hydrolysis formula food and preparation method thereof | |
AU2020103452A4 (en) | Method for preparing liquid milk based on reduced allergenicity of cow's milk | |
JP3153237B2 (en) | Protein hydrolyzate | |
EP2124603B1 (en) | Milk protein hydrolyzates with reduced immunogenic potential | |
US20090297689A1 (en) | Peptidylarginine deiminase and uses thereof in the production of citrullinated proteins and peptides | |
JP2011530274A (en) | Proteolytic composition stable under acidic conditions | |
US20080305212A1 (en) | Protein Hydrolysate Compositions Having Improved Sensory Characteristics and Physical Properties | |
US6908633B2 (en) | Protein hydrolyzates, process for producing the same and drinks and foods containing the protein hydrolyzates | |
CN115867144A (en) | Taste improvement of protein | |
TWI284537B (en) | Blood-viscosity reducing agent | |
US20060159826A1 (en) | Soy protein for infant formula | |
US20240074457A1 (en) | Method for producing proteolytic product, and enzyme agent | |
US20220007678A1 (en) | Soluble legume protein | |
US20170202230A1 (en) | Milk clotting aspartic protease enzyme composition | |
JP2003250460A (en) | Method for modifying functionality of milk protein | |
EP4268602A1 (en) | Method for producing rice protein-containing liquid composition | |
JP3979543B2 (en) | Antiallergic agent and method for producing the same | |
CN115211509A (en) | Compound enzyme preparation for preparing liquid vegetable protein base material and application thereof | |
AU650314B2 (en) | A process for the production of hydrolyzed proteins and the product thereof | |
BRPI0710694A2 (en) | methods for extracting one or more yeast components and for producing a yeast extract, and use of a purified phospholipase | |
US20230329262A1 (en) | Method of manufacturing processed chickpea milk | |
JPH11225686A (en) | Casein hydrolysate and its production | |
Islam et al. | Enzyme processing of soy flour with minimized protein loss | |
CN104970183A (en) | Soluble soya bean protein, preparation method and application thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |